Detailansicht

Wissensnetz

Person

Annamaria Biczok

Ärztin

Name	Annamaria Biczok
Ort	Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Ärztin (charakteristischer Beruf)
Weitere Angaben	Ulm, Univ., Tag der Promotion: 09.02.2018 Habilitationsschrift, Medizinische Fakultät, Ludwig-Maximilians-Universität München, 2024
Datensatztyp	Person
GND-Nummer	115860713X
Datensatz-ID	115860713X
Beteiligt an alle anzeigen Perifocal edema is a risk factor for preoperative seizures in patients with meningioma WHO grade 2 and 3 Identifikation prognostischer Variablen zur Optimierung der Therapie von Meningeomen The value of [18F]FET PET and somatostatin receptor imaging for differentiating pseudoprogression in residual meningioma Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1 Mutational signature of extracranial meningioma metastases and their respective primary tumors Intraoperative ultrasonography in laminectomy for degenerative cervical spondylotic myelopathy: a clinical and radiological evaluation Detection of impending perfusion deficits by intraoperative computed tomography (iCT) in aneurysm surgery of the anterior circulation Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome 18F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas Der Einfluss eines chirurgisch induzierten neurologischen Defizits auf das Langzeitüberleben bei Glioblastom-Patienten : eine Matched-Pair Analyse

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Annamaria Biczok

Perifocal edema is a risk factor for preoperative seizures in patients with meningioma WHO grade 2 and 3

Identifikation prognostischer Variablen zur Optimierung der Therapie von Meningeomen

The value of [18F]FET PET and somatostatin receptor imaging for differentiating pseudoprogression in residual meningioma

Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1

Mutational signature of extracranial meningioma metastases and their respective primary tumors

Intraoperative ultrasonography in laminectomy for degenerative cervical spondylotic myelopathy: a clinical and radiological evaluation

Detection of impending perfusion deficits by intraoperative computed tomography (iCT) in aneurysm surgery of the anterior circulation

Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas

Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I

Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas

PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis

Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome

18F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas

Der Einfluss eines chirurgisch induzierten neurologischen Defizits auf das Langzeitüberleben bei Glioblastom-Patienten : eine Matched-Pair Analyse